معرفی
Henk De Feyter serves as an Associate Professor of Radiology and Biomedical Imaging at Yale School of Medicine, with primary appointments in the Department of Radiology & Biomedical Imaging. He maintains affiliations with multiple research entities including the Bioimaging Sciences division, Deuterium Metabolic Imaging (DMI) Developmental Therapeutics program, Magnetic Resonance Research Center, and Yale Biomedical Imaging Institute.
Dr. De Feyter completed his postdoctoral training at Yale University (2010) following a PhD from Eindhoven University of Technology's Department of Biomedical Engineering. His educational background includes Master's degrees from Maastricht University (Department of Health, Medicine and Life Sciences) and Ghent University (Department of Rehabilitation Sciences).
His research program centers on developing and applying Deuterium Metabolic Imaging techniques to visualize metabolic processes in vivo. Dr. De Feyter specializes in creating novel imaging methodologies to track metabolic pathways using deuterium-labeled substrates, with particular applications in brain tumor characterization, cardiac metabolism, and liver function assessment. His interdisciplinary approach combines physics, engineering, and clinical medicine to develop diagnostic tools that bridge basic science and patient care.
Analysis of Dr. De Feyter's publication record reveals a consistent focus on advancing metabolic imaging technologies, particularly Deuterium Metabolic Imaging. His work demonstrates growing clinical relevance across neuro-oncology, cardiology, and hepatology, with increasing emphasis on translating research techniques to clinical applications. The interdisciplinary nature of his publications reflects collaborations across multiple scientific domains.
Dr. De Feyter maintains active research collaborations with experts across multiple disciplines, including neurology, oncology, physics, and biochemistry. His research program appears to be supported by substantial grant funding focused on developing metabolic imaging techniques for clinical applications, particularly in brain tumor imaging and neurological disorders.
As part of Yale's Magnetic Resonance Research Center and Yale Biomedical Imaging Institute, Dr. De Feyter contributes to a collaborative environment dedicated to advancing imaging technologies. His work on metabolic imaging represents a significant contribution to the development of non-invasive diagnostic tools that could transform how metabolic disorders and cancers are detected and monitored.
